Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study

Opioid use disorder (OUD) is associated with physical, social, psychological, and economic burden. This analysis assessed the effects of RBP-6000, referred to as BUP-XR (extended-release buprenorphine), a subcutaneously injected, monthly buprenorphine treatment for OUD compared with placebo on patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Walter, Nadipelli, Vijay R., Solem, Caitlyn T., Ronquest, Naoko A., Yeh, Yu-Chen, Learned, Susan M., Mehra, Vishaal, Heidbreder, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844648/
https://www.ncbi.nlm.nih.gov/pubmed/30844878
http://dx.doi.org/10.1097/ADM.0000000000000517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844648/
https://www.ncbi.nlm.nih.gov/pubmed/30844878
http://dx.doi.org/10.1097/ADM.0000000000000517

Ejemplares similares